SCYNEXIS

SCYNEXIS Shareholder Yield

Shareholder Yield of SCYNEXIS (SCYX) as of Oct 8, 2026.

Shareholder Yield

0.00

Last updated:

Shareholder Yield of SCYNEXIS is 2025 0.00 . Shareholder Yield of SCYNEXIS was 2024 0.00 . It decreases by % lower compared to the previous year.

The SCYNEXIS Shareholder Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Shareholder Yield
Date
Shareholder Yield
Jan 1, 2018
100.71 USD
Jan 1, 2019
147.38 USD
Jan 1, 2020
32.52 USD
Jan 1, 2021
122.56 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
The SCYNEXIS Shareholder Yield history
YEARShareholder YieldYoY
0.00—
0.00—
0.00—
0.00-100.00%
122.56 %+276.85%
32.52 %-77.93%
147.38 %+46.35%
100.71 %+207.07%
32.80 %-63.26%
89.27 %-32.31%
131.87 %-33.78%
199.14 %—
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

On Eulerpool you can find the complete historical development of Shareholder Yield SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Shareholder yield combines dividend yield and buyback yield to show the total cash return to shareholders. It captures both dividends and share repurchases.

To evaluate Shareholder Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Shareholder Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Shareholder Yield's SCYNEXIS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — SCYNEXIS

All Key Metrics — SCYNEXIS